Page last updated: 2024-09-04

asenapine and butaclamol

asenapine has been researched along with butaclamol in 1 studies

Compound Research Comparison

Studies
(asenapine)
Trials
(asenapine)
Recent Studies (post-2010)
(asenapine)
Studies
(butaclamol)
Trials
(butaclamol)
Recent Studies (post-2010) (butaclamol)
2655020945016

Protein Interaction Comparison

ProteinTaxonomyasenapine (IC50)butaclamol (IC50)
D(2) dopamine receptorHomo sapiens (human)0.0023
DRattus norvegicus (Norway rat)0.0053
D(3) dopamine receptorRattus norvegicus (Norway rat)0.0053
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.0053
D(4) dopamine receptorRattus norvegicus (Norway rat)0.0053
D(3) dopamine receptorHomo sapiens (human)0.0112
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0034

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Audinot, V; Chaput, C; Conte, C; Gavaudan, S; Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L1

Other Studies

1 other study(ies) available for asenapine and butaclamol

ArticleYear
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
    European journal of pharmacology, 1998, Aug-21, Volume: 355, Issue:2-3

    Topics: Animals; Antipsychotic Agents; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Sulfur Radioisotopes

1998